Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Ocelot Bio Appoints Lise Kjems, M.D., Ph.D., as Chief Medical Officer
Ocelot Bio, a clinical-stage biopharmaceutical company focused on the development of innovative therapeutics to treat […]
Daewoong Pharmaceutical and Sygnature Discovery Announce Drug Discovery Research Collaboration
Daewoong Pharmaceutical has entered a research collaboration with Sygnature Discovery to expand its global open […]
MapKure, BeiGene and SpringWorks Present Clinical Data on BGB-3245, a Selective Next-Generation B-RAF Inhibitor, in Adult Patients with Advanced or Refractory Solid Tumors
MapKure, BeiGene and SpringWorks Therapeutics, today announced that they will present updated clinical data from the […]
Lipella Pharmaceuticals Enters Manufacturing Collaboration Agreement with Cook MyoSite
Lipella Pharmaceuticals, a clinical-stage biotechnology company addressing serious diseases with significant unmet need, has entered […]
Complement Therapeutics Secures €72 Million in Series A Financing to Advance Novel Therapies Targeting Complement-Mediated Diseases
Complement Therapeutics, a preclinical stage biotechnology company developing novel therapeutics for complement mediated diseases, has […]
Epic Sciences Raises $24M in Series G Financing to Continue Funding Commercialization of DefineMBC
Epic Sciences, a privately held diagnostics company, has completed a $24 million Series G which […]
M2GEN Rebrands to Aster Insights
M2GEN, an oncology bioinformatics company with the most advanced lifetime-consented clinicogenomic data to accelerate medical […]
TORL BioTherapeutics Launches with $158 Million Series B Financing to Advance Development of Novel Oncology Biologics
TORL BioTherapeutics, a biopharmaceutical company focused on developing new biologics for cancer treatment, has announced […]
YDS Pharmatech Appoints Dr. Robert Sullivan as Head of Medicinal Chemistry
YDS Pharmatech, a computational drug discovery company specializing in induced proximity, today announced the appointment […]
Turn Biotechnologies Sharpens Immunology Focus by Adding Two Cell Therapy Specialists to its Medical Advisory Board
Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines for untreatable, age-related conditions, announced […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more